Overview
Acquired metabolic neuropathy is a condition where nerve damage occurs as a result of metabolic problems that develop during a person's lifetime, rather than being inherited from birth. This means the nerves — especially those in the hands and feet — become damaged because of an underlying metabolic disorder such as diabetes, kidney failure, liver disease, thyroid problems, or nutritional deficiencies (like lack of vitamin B12). The term 'acquired' means this is not something you are born with but something that develops over time due to another health condition. It is important to note that this specific Orphanet entry (206616) is marked as OBSOLETE, meaning it is no longer actively used as a standalone classification. Patients with nerve damage from metabolic causes are now typically classified under more specific diagnoses based on the underlying cause (for example, diabetic neuropathy or uremic neuropathy from kidney disease). Symptoms commonly include numbness, tingling, burning pain, and weakness in the hands and feet, which can gradually spread. Some people also experience problems with balance, digestion, or blood pressure regulation. Treatment focuses on managing the underlying metabolic condition and relieving nerve pain. When the root cause is identified and treated early, nerve damage can sometimes be slowed or partially reversed. Pain management, physical therapy, and lifestyle changes are important parts of care.
Key symptoms:
Numbness or tingling in hands and feetBurning or shooting pain in the extremitiesMuscle weakness in the legs or armsLoss of balance or coordinationSensitivity to touchDifficulty walkingMuscle crampsLoss of reflexesDigestive problems such as nausea or constipationDizziness when standing upDifficulty gripping objectsFeeling of wearing invisible gloves or socksFoot ulcers or wounds that heal slowly
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsUniversitas Sebelas Maret — PHASE2, PHASE3
National Taiwan University Hospital — NA
University of Rochester — PHASE2
Taipei Veterans General Hospital, Taiwan — NA
Ka-Wai Ho — NA
Ain Shams University — PHASE2
Cairo University
Ain Shams University — PHASE4
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Acquired metabolic neuropathy.
10 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Acquired metabolic neuropathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Acquired metabolic neuropathy.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Acquired metabolic neuropathy.
Start the conversation →Latest news about OBSOLETE: Acquired metabolic neuropathy
No recent news articles for OBSOLETE: Acquired metabolic neuropathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the specific metabolic cause of my neuropathy, and how can we treat it?,Can the nerve damage I already have be reversed, or is the goal to prevent it from getting worse?,What medications are best for managing my nerve pain, and what are their side effects?,Should I see any additional specialists, such as a pain management doctor or physical therapist?,What can I do at home to protect my feet and prevent injuries?,Are there any dietary changes or supplements that could help my condition?,How often should I have follow-up nerve testing to monitor my progress?
Common questions about OBSOLETE: Acquired metabolic neuropathy
What is OBSOLETE: Acquired metabolic neuropathy?
Acquired metabolic neuropathy is a condition where nerve damage occurs as a result of metabolic problems that develop during a person's lifetime, rather than being inherited from birth. This means the nerves — especially those in the hands and feet — become damaged because of an underlying metabolic disorder such as diabetes, kidney failure, liver disease, thyroid problems, or nutritional deficiencies (like lack of vitamin B12). The term 'acquired' means this is not something you are born with but something that develops over time due to another health condition. It is important to note that
How is OBSOLETE: Acquired metabolic neuropathy inherited?
OBSOLETE: Acquired metabolic neuropathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Acquired metabolic neuropathy typically begin?
Typical onset of OBSOLETE: Acquired metabolic neuropathy is adult. Age of onset can vary across affected individuals.
Are there clinical trials for OBSOLETE: Acquired metabolic neuropathy?
Yes — 10 recruiting clinical trials are currently listed for OBSOLETE: Acquired metabolic neuropathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.